Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Heptavalent Pneumococcal Conjugate Vaccine"" wg kryterium: Temat


Tytuł :
Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency.
Autorzy :
Løchen A; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK.; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Croucher NJ; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK. .; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK. .
Anderson RM; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK.; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Nov 04; Vol. 10 (1), pp. 18977. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*epidemiology
Streptococcus pneumoniae/*classification
Adult ; Australia/epidemiology ; Europe/epidemiology ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Incidence ; Infant ; Male ; North America/epidemiology ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Pneumococcal Vaccines/immunology ; Serogroup ; Streptococcus pneumoniae/immunology ; Streptococcus pneumoniae/isolation & purification
Czasopismo naukowe
Tytuł :
The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
Autorzy :
Agudelo CI; Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.
Castañeda-Orjuela C; Observatorio Nacional de Salud, Instituto Nacional de Salud, Bogotá, Colombia.
Brandileone MCC; Bacteriology Center, Adolfo Lutz Institute, São Paulo, Brazil.
Echániz-Aviles G; Centro de Investigaciones Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
Almeida SCG; Bacteriology Center, Adolfo Lutz Institute, São Paulo, Brazil.
Carnalla-Barajas MN; Centro de Investigaciones Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
Regueira M; Departamento Bacteriología, INEI-ANLIS Dr Carlos G Malbrán, Buenos Aires, Argentina.
Fossati S; Departamento Bacteriología, INEI-ANLIS Dr Carlos G Malbrán, Buenos Aires, Argentina.
Alarcón P; Sección Bacteriología, Instituto de Salud Pública de Chile, Santiago, Chile.
Araya P; Sección Bacteriología, Instituto de Salud Pública de Chile, Santiago, Chile.
Duarte C; Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.
Sánchez J; Laboratorio de Microbiología-DEI, Hospital Infantil Dr Robert Reid Cabral, Santo Domingo, Dominican Republic.
Novas M; Laboratorio de Microbiología-DEI, Hospital Infantil Dr Robert Reid Cabral, Santo Domingo, Dominican Republic.
Toraño-Peraza G; Departamento de Bacteriología y Micología, Instituto Pedro Kouri, La Habana, Cuba.
Rodríguez-Ortega M; Departamento de Bacteriología y Micología, Instituto Pedro Kouri, La Habana, Cuba.
Chamorro-Cortesi G; Departamento de Bacteriología y Micología, Laboratorio Central de Salud Pública, Asunción, Paraguay.
Kawabata A; Departamento de Bacteriología y Micología, Laboratorio Central de Salud Pública, Asunción, Paraguay.
García-Gabarrot G; Departamento de Laboratorios, Ministerio de Salud, Montevideo, Uruguay.
Camou T; Departamento de Laboratorios, Ministerio de Salud, Montevideo, Uruguay.
Spadola E; Sección de Aislamiento e Identificación Bacteriana, Instituto Nacional de Higiene Rafael Rangel, Caracas, Venezuela.
Payares D; Sección de Aislamiento e Identificación Bacteriana, Instituto Nacional de Higiene Rafael Rangel, Caracas, Venezuela.
Andrade AL; Instituto de Patología Tropical e Saúde Pública, Universidade Federal de Goias, Goiania, Goias, Brazil.
Di Fabio JL; Rockville, MD, USA.
Castañeda E; Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia. Electronic address: .
Pokaż więcej
Corporate Authors :
SIREVA Working Group
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Mar; Vol. 21 (3), pp. 405-417. Date of Electronic Publication: 2020 Sep 25.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Serotyping*
Vaccines, Conjugate*
Pneumococcal Infections/*microbiology
Streptococcus pneumoniae/*classification
Caribbean Region ; Child, Preschool ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Latin America ; Male ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Retrospective Studies ; Streptococcus pneumoniae/isolation & purification
Czasopismo naukowe
Tytuł :
Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel, 2002-2016.
Autorzy :
Triadou D; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Givon-Lavi N; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Greenberg D; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ben-Shimol S; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Pokaż więcej
Źródło :
Infectious diseases (London, England) [Infect Dis (Lond)] 2020 Mar; Vol. 52 (3), pp. 186-195. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine*
Community-Acquired Infections/*epidemiology
Community-Acquired Infections/*prevention & control
Pneumonia, Pneumococcal/*epidemiology
Pneumonia, Pneumococcal/*prevention & control
Arabs/statistics & numerical data ; Child, Preschool ; Community-Acquired Infections/complications ; Humans ; Immunologic Factors ; Incidence ; Infant ; Influenza A virus/isolation & purification ; Influenza, Human/epidemiology ; Israel/epidemiology ; Jews/statistics & numerical data ; Nose/virology ; Pleural Effusion/microbiology ; Prospective Studies ; Pulmonary Alveoli ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Viruses/isolation & purification
Czasopismo naukowe
Tytuł :
Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016.
Autorzy :
Adebanjo TA; Epidemic Intelligence Service and.; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pondo T; Epidemic Intelligence Service and.
Yankey D; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Hill HA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Gierke R; Epidemic Intelligence Service and.
Apostol M; California Emerging Infections Program, Oakland, California.
Barnes M; Colorado Department of Public Health and Environment, Denver, Colorado.
Petit S; Connecticut Department of Public Health, Hartford, Connecticut.
Farley M; School of Medicine, Emory University and Atlanta Department of Veterans Affairs Medical Center, Atlanta, Georgia.
Harrison LH; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Holtzman C; Minnesota Department of Health, St Paul, Minnesota.
Baumbach J; New Mexico Department of Health, Santa Fe, New Mexico.
Bennett N; School of Medicine and Dentistry, University of Rochester, Rochester, New York.
McGuire S; New York State Department of Health, Albany, New York.
Thomas A; Oregon Public Health Division, Portland, Oregon; and.
Schaffner W; Vanderbilt University, Nashville, Tennessee.
Beall B; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Whitney CG; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pilishvili T; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; .
Pokaż więcej
Źródło :
Pediatrics [Pediatrics] 2020 Mar; Vol. 145 (3). Date of Electronic Publication: 2020 Feb 13.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine*
Pneumococcal Vaccines*
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*prevention & control
Child, Preschool ; Female ; Humans ; Incidence ; Infant ; Male ; Treatment Failure ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Pneumococcal conjugate vaccines for preventing acute otitis media in children.
Autorzy :
de Sévaux JL; Department of Emergency Medicine, Ziekenhuis St Jansdal, Harderwijk, Netherlands.; Department of Internal Medicine, Ziekenhuis Gelderse Vallei, Ede, Netherlands.
Venekamp RP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Lutje V; Cochrane Infectious Diseases Group, Liverpool School of Tropical Medicine, Liverpool, UK.
Hak E; Groningen Research Institute of Pharmacy, University Groningen, 9713 AV Groningen, Netherlands.
Schilder AG; evidENT, Ear Institute, University College London, London, UK.; Julius Center for Health Sciences and Primary Care & Department of Otorhinolaryngology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; National Institute of Health Research, University College London Hospitals Biomedical Research Centre, London, UK.
Sanders EA; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Center for Infectious Diseases, The National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Damoiseaux RA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Nov 24; Vol. 11. Cochrane AN: CD001480. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Pneumococcal Vaccines*/adverse effects
Pneumococcal Vaccines*/therapeutic use
Otitis Media/*prevention & control
Acute Disease ; Age Factors ; Child ; Child, Preschool ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/adverse effects ; Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use ; Humans ; Infant ; Male ; Otitis Media/microbiology ; Otitis Media with Effusion/drug therapy ; Randomized Controlled Trials as Topic ; Vaccines, Conjugate/adverse effects ; Vaccines, Conjugate/therapeutic use
Czasopismo naukowe
Tytuł :
IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infections.
Autorzy :
Cavaliere FM; Department of Molecular Medicine, Sapienza University, Rome, Italy.
Graziani S; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Del Duca E; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Bilotta C; Department of Molecular Medicine, Sapienza University, Rome, Italy.
Sgrulletti M; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Quinti I; Department of Molecular Medicine, Sapienza University, Rome, Italy.
Moschese V; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Pokaż więcej
Źródło :
Scandinavian journal of immunology [Scand J Immunol] 2021 Jan; Vol. 93 (1), pp. e12955. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Letter
MeSH Terms :
Antibodies, Bacterial/*blood
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Immunoglobulin A/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
Antigens, Bacterial/immunology ; Child ; Child, Preschool ; Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Polysaccharides, Bacterial/immunology ; Respiratory Tract Infections/immunology ; Respiratory Tract Infections/microbiology
Opinia redakcyjna
Tytuł :
Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up.
Autorzy :
MacIntyre CR; Biosecurity Program, Kirby Institute, Faculty of Medicine, University of New South Wales, Sydney, Australia. Electronic address: .
Ridda I; Independent Scholar, Sydney, Australia.
Trent MJ; Biosecurity Program, Kirby Institute, Faculty of Medicine, University of New South Wales, Sydney, Australia. Electronic address: .
McIntyre P; National Centre for Immunisation Research and Surveillance, University of Sydney, Sydney, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Aug 14; Vol. 37 (35), pp. 5016-5024. Date of Electronic Publication: 2019 Jul 09.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunogenicity, Vaccine*
Antibodies, Bacterial/*blood
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Pneumococcal Vaccines/*immunology
Aged ; Australia ; Female ; Follow-Up Studies ; Frail Elderly ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Hospitalization ; Humans ; Immunization Schedule ; Immunoglobulin G/blood ; Male ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Serogroup ; Streptococcus pneumoniae ; Time Factors
Czasopismo naukowe
Tytuł :
Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
Autorzy :
Choi YH; Statistics, Modelling and Economics Department, Data and Analytical Sciences, National Infection Service, Public Health England, London, United Kingdom.
Andrews N; Statistics, Modelling and Economics Department, Data and Analytical Sciences, National Infection Service, Public Health England, London, United Kingdom.
Miller E; Immunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2019 Jul 03; Vol. 16 (7), pp. e1002845. Date of Electronic Publication: 2019 Jul 03 (Print Publication: 2019).
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Immunization Programs*
Immunization Schedule*
Immunogenicity, Vaccine*
Models, Theoretical*
Vaccination*
Community-Acquired Infections/*prevention & control
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*administration & dosage
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Community-Acquired Infections/immunology ; Community-Acquired Infections/mortality ; Community-Acquired Infections/transmission ; England/epidemiology ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Immunity, Herd ; Incidence ; Infant ; Infant, Newborn ; Middle Aged ; Pneumococcal Infections/immunology ; Pneumococcal Infections/mortality ; Pneumococcal Infections/transmission ; Pneumococcal Vaccines/immunology ; Prevalence ; Program Evaluation ; Time Factors ; Wales/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Differences in the Impact of Pneumococcal Serotype Replacement in Individuals With and Without Underlying Medical Conditions.
Autorzy :
Weinberger DM; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
Warren JL; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut.
Dalby T; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Shapiro ED; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.; Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
Valentiner-Branth P; Infectious Disease Epidemiology and Prevention, Statens Serum Institut.
Slotved HC; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Harboe ZB; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.; Department of Infectious Diseases and Pulmonary Medicine, Nordsjaellands Hospital, Copenhagen University Hospital, Denmark.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Jun 18; Vol. 69 (1), pp. 100-106.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunization Programs*
Heptavalent Pneumococcal Conjugate Vaccine/*standards
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*standards
Adolescent ; Adult ; Aged ; Bayes Theorem ; Child ; Child, Preschool ; Denmark ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Immunologic Surveillance ; Incidence ; Middle Aged ; Pneumococcal Infections/microbiology ; Pneumococcal Vaccines/administration & dosage ; Registries ; Serogroup ; Streptococcus pneumoniae/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Making sense of differences in pneumococcal serotype replacement.
Autorzy :
Lewnard JA; Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA. Electronic address: .
Hanage WP; Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA, USA.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2019 Jun; Vol. 19 (6), pp. e213-e220. Date of Electronic Publication: 2019 Jan 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Pharmacogenomic Variants/*genetics
Pneumococcal Infections/*drug therapy
Pneumococcal Infections/*prevention & control
Streptococcus pneumoniae/*genetics
Streptococcus pneumoniae/*immunology
Adult ; Aged ; Aged, 80 and over ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Male ; Middle Aged ; Pneumococcal Infections/epidemiology ; Serotyping ; United Kingdom/epidemiology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Early clinical predictors for the prognosis of invasive pneumococcal disease.
Autorzy :
Wu S; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Guo X; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Xu Z; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Han M; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Huang L; Laboratory department, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Tao Y; Laboratory department, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Li Y; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Li Y; Nephrology department, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Zhang T; Key Laboratory of Public Health Safety, Ministry of Education-department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
Bai Z; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Sep 04; Vol. 20 (1), pp. 651. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article
MeSH Terms :
Pneumococcal Infections/*microbiology
Pneumococcal Infections/*mortality
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Child, Preschool ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use ; Hospital Mortality ; Humans ; Infant ; Male ; Microbial Sensitivity Tests ; Pneumococcal Infections/drug therapy ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/therapeutic use ; Prognosis ; Retrospective Studies ; Risk Factors ; Sepsis/microbiology ; Streptococcus pneumoniae/isolation & purification ; Vaccination Coverage
Czasopismo naukowe
Tytuł :
Impact of PCV7 vaccination on nasopharyngeal carriage and antimicrobial resistance among children in Turkey.
Autorzy :
Kaya Gursoy B; Department of Pediatrics, Faculty of Medicine, Gazi University Ankara, Turkey. .
Beyazova U; Department of Pediatrics, Faculty of Medicine, Gazi University Ankara, Turkey. .
Oguz MM; Department of Pediatrics, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey. .
Demirel F; Department of Microbiology, Faculty of Medicine, Gazi University Ankara, Turkey. .
Ozkan S; Department of Public Health, Faculty of Medicine, Gazi University Ankara, Turkey. .
Sultan N; Department of Microbiology, Faculty of Medicine, Gazi University Ankara, Turkey. .
Nar Otgun S; National Respiratory Pathogens Reference Laboratory, Public Health Institution of Turkey, Ankara, Turkey. .
Pokaż więcej
Źródło :
Journal of infection in developing countries [J Infect Dev Ctries] 2019 Mar 31; Vol. 13 (3), pp. 227-232. Date of Electronic Publication: 2019 Mar 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Bacterial*
Carrier State/*microbiology
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Nasopharynx/*microbiology
Pneumococcal Infections/*prevention & control
Streptococcus pneumoniae/*classification
Streptococcus pneumoniae/*isolation & purification
Carrier State/epidemiology ; Female ; Follow-Up Studies ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Hospitals, Pediatric ; Humans ; Infant ; Male ; Microbial Sensitivity Tests ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/microbiology ; Prevalence ; Serogroup ; Serotyping ; Tertiary Care Centers ; Turkey
Czasopismo naukowe
Tytuł :
Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia.
Autorzy :
Rockett RJ; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia. .; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Camperdown, 2050, Australia. .
Oftadeh S; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.; NSW Pneumococcal Reference Laboratory, Institute of Clinical Pathology and Medical Research - NSW Health Pathology, Westmead, 2145, Australia.
Bachmann NL; Centenary Institute, The University of Sydney, Camperdown, 2050, Australia.
Timms VJ; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.
Kong F; NSW Pneumococcal Reference Laboratory, Institute of Clinical Pathology and Medical Research - NSW Health Pathology, Westmead, 2145, Australia.
Gilbert GL; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Camperdown, 2050, Australia.
Sintchenko V; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.; NSW Pneumococcal Reference Laboratory, Institute of Clinical Pathology and Medical Research - NSW Health Pathology, Westmead, 2145, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Camperdown, 2050, Australia.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2018 Nov 16; Vol. 8 (1), pp. 16969. Date of Electronic Publication: 2018 Nov 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Pneumococcal Infections/*immunology
Pneumococcal Vaccines/*immunology
Streptococcus pneumoniae/*immunology
Child, Preschool ; Genome, Bacterial/genetics ; Genome-Wide Association Study ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Immunization Schedule ; Incidence ; Infant ; Multilocus Sequence Typing ; New South Wales/epidemiology ; Phylogeny ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Pneumococcal Vaccines/classification ; Serogroup ; Streptococcus pneumoniae/classification ; Streptococcus pneumoniae/genetics ; Vaccines, Conjugate/administration & dosage ; Vaccines, Conjugate/immunology
Czasopismo naukowe
Tytuł :
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
Autorzy :
Tan CY; Pfizer Inc., Collegeville, Pennsylvania, USA.
Immermann FW; Pfizer Inc., Pearl River, New York, USA.
Sebastian S; Affinivax, Cambridge, Massachusetts, USA.
Pride MW; Pfizer Inc., Pearl River, New York, USA.
Pavliakova D; Pfizer Inc., Pearl River, New York, USA.
Belanger KA; Pfizer Inc., Pearl River, New York, USA.
Watson W; Pfizer Inc., Collegeville, Pennsylvania, USA.
Scott DA; Pfizer Inc., Pearl River, New York, USA.
Sidhu M; Pfizer Inc., Pearl River, New York, USA.
Jansen KU; Pfizer Inc., Pearl River, New York, USA.
Giardina PC; Pfizer Inc., Pearl River, New York, USA .
Pokaż więcej
Źródło :
MSphere [mSphere] 2018 Aug 08; Vol. 3 (4). Date of Electronic Publication: 2018 Aug 08.
Typ publikacji :
Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Bacterial/*blood
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Immunoassay/*methods
Immunoglobulin G/*blood
Pneumococcal Vaccines/*immunology
Polysaccharides, Bacterial/*immunology
Streptococcus pneumoniae/*immunology
Clinical Trials as Topic ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Pneumococcal Vaccines/administration & dosage ; Serum/immunology
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I.
Autorzy :
Martínez CPD; Children University Hospital 'Juan Manuel Márquez', Marianao, Havana 11400, Cuba. Electronic address: .
Linares-Pérez N; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Toledo-Romaní ME; Tropical Medicine Institute 'Pedro Kourí', Havana, Cuba. Electronic address: .
Delgado YR; University Hospital 'Juan Manuel Márquez', Marianao, Havana, Cuba. Electronic address: .
Gómez RP; Children University Hospital 'Juan Manuel Márquez', Marianao, Havana 11400, Cuba. Electronic address: .
Moreno BP; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Rodriguez-Noda LM; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Sosa MM; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Mederos DS; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
García-Rivera D; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Valdés-Balbín Y; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Goldblatt D; World Health Organization (WHO) Pneumococcal Serology Reference Laboratory, University College London, Institute of Child Health, London, United Kingdom. Electronic address: .
Vérez-Bencomo V; Finlay Vaccine Institute, 200 and 21 Street, Playa, Havana 11600, Cuba. Electronic address: .
Pokaż więcej
Corporate Authors :
Havana-Pneumococci Clinical Group
Finlay-Pneumococci Project
Źródło :
Vaccine [Vaccine] 2018 Aug 06; Vol. 36 (32 Pt B), pp. 4944-4951. Date of Electronic Publication: 2018 Jul 10.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*therapeutic use
Pneumococcal Infections/*prevention & control
Vaccines, Conjugate/*therapeutic use
Antibodies, Bacterial/immunology ; Double-Blind Method ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Immunization Schedule ; Infant ; Male ; Pneumococcal Infections/immunology ; Vaccines, Conjugate/administration & dosage
Czasopismo naukowe
Tytuł :
Influence of pneumococcal conjugate vaccines on acute otitis media in Japan.
Autorzy :
Sasaki A; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Hiroshima University, Hiroshima, Japan.
Kunimoto M; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Hiroshima University, Hiroshima, Japan; Kunimoto ENT Clinic, Hiroshima, Japan. Electronic address: .
Takeno S; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Hiroshima University, Hiroshima, Japan.
Sumiya T; Graduate School of Integrated Arts and Sciences, Hiroshima University, Hiroshima, Japan.
Ishino T; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Hiroshima University, Hiroshima, Japan.
Sugino H; Sugino Pediatric Clinic, Hiroshima, Japan.
Hirakawa K; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło :
Auris, nasus, larynx [Auris Nasus Larynx] 2018 Aug; Vol. 45 (4), pp. 718-721. Date of Electronic Publication: 2017 Nov 01.
Typ publikacji :
Journal Article
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*therapeutic use
Otitis Media/*epidemiology
Pneumococcal Vaccines/*therapeutic use
Acute Disease ; Adolescent ; Child ; Child, Preschool ; Female ; Financing, Government ; Healthcare Financing ; Heptavalent Pneumococcal Conjugate Vaccine/economics ; Humans ; Incidence ; Infant ; Japan/epidemiology ; Male ; Middle Ear Ventilation/trends ; Otitis Media/surgery ; Pneumococcal Vaccines/economics
Czasopismo naukowe
Tytuł :
Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children.
Autorzy :
Ben-Shimol S; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Dagan R; Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Givon-Lavi N; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Avital D; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Bar-Ziv J; Department of Radiology, Hadassah Medical Center, Jerusalem, Israel.
Greenberg D; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Jun 24; Vol. 71 (1), pp. 177-187.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Pneumococcal Infections*
Pneumococcal Vaccines*
Aged ; Australia ; Child ; Child, Preschool ; Heptavalent Pneumococcal Conjugate Vaccine ; Humans ; Incidence ; Infant ; Israel/epidemiology ; Radiography ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians.
Autorzy :
Meder KN; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children's Hospital at Westmead, Sydney, Australia.; National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.
Jayasinghe S; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children's Hospital at Westmead, Sydney, Australia.; University of Sydney, Sydney, Australia.
Beard F; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children's Hospital at Westmead, Sydney, Australia.; University of Sydney, Sydney, Australia.
Dey A; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children's Hospital at Westmead, Sydney, Australia.; University of Sydney, Sydney, Australia.
Kirk M; National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.
Cook H; Centre for Disease Control, Northern Territory Department of Health, Darwin, Australia.
Strachan J; Communicable Disease Epidemiology and Surveillance, Department of Health and Human Services, Melbourne, Australia.
Sintchenko V; University of Sydney, Sydney, Australia.; Centre for Infectious Diseases and Microbiology-Public Health, The Institute for Clinical Pathology and Medical Research , Westmead Hospital, Sydney, Australia.
Smith H; Public Health Microbiology, Forensic and Scientific Services, Queensland Department of Health, Coopers Plains, Australia.
Giele C; Public Health Division, Department of Health Western Australia, Perth, Australia.
Howden B; Microbiological Diagnostic Unit, Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.
Krause V; Centre for Disease Control, Northern Territory Department of Health, Darwin, Australia.
Mcintyre P; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children's Hospital at Westmead, Sydney, Australia.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Jun 10; Vol. 70 (12), pp. 2607-2615.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pneumococcal Infections*/epidemiology
Pneumococcal Infections*/prevention & control
Pneumonia*/epidemiology
Pneumonia*/prevention & control
Australia/epidemiology ; Child ; Child, Preschool ; Heptavalent Pneumococcal Conjugate Vaccine ; Hospitalization ; Humans ; Incidence ; Infant ; Pneumococcal Vaccines ; Serogroup ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
Autorzy :
Toda H; Department of Clinical Laboratory, Kindai University Hospital, Japan; Laboratory of Molecular Medical Microbiology, Department of Biomedical Informatics, Osaka University Graduate School of Medicine, Japan. Electronic address: .
Tanaka Y; Department of Clinical Laboratory Medicine, Kindai University Faculty of Medicine, Japan.
Satoh K; Clinical Research Center, Kindai University Hospital, Japan.
Komatsu M; Department of Clinical Laboratory Science, Tenri Health Care University, Japan.
Wada Y; Department of Clinical Laboratory, Hyogo Medical University Hospital, Japan.
Tobe T; Laboratory of Molecular Medical Microbiology, Department of Biomedical Informatics, Osaka University Graduate School of Medicine, Japan.
Kamisako T; Department of Clinical Laboratory Medicine, Kindai University Faculty of Medicine, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2020 May; Vol. 26 (5), pp. 451-458. Date of Electronic Publication: 2019 Dec 20.
Typ publikacji :
Journal Article
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*therapeutic use
Pneumococcal Infections/*epidemiology
Streptococcus pneumoniae/*classification
Streptococcus pneumoniae/*genetics
Adolescent ; Adult ; Child ; Community-Acquired Infections/epidemiology ; Community-Acquired Infections/genetics ; Community-Acquired Infections/microbiology ; Community-Acquired Infections/prevention & control ; Electrophoresis, Gel, Pulsed-Field ; Humans ; Immunologic Factors/therapeutic use ; Japan/epidemiology ; Microbial Sensitivity Tests ; Molecular Epidemiology ; Multilocus Sequence Typing ; Penicillin Resistance ; Penicillin-Binding Proteins/genetics ; Pneumococcal Infections/genetics ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/prevention & control ; Serogroup ; Serotyping ; Streptococcus pneumoniae/isolation & purification ; Vaccines, Conjugate/therapeutic use
Czasopismo naukowe
Tytuł :
Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study.
Autorzy :
Jayasinghe S; National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead and Discipline of Child and Adolescent Health, Medical School, University of Sydney, Sydney, Australia.
Chiu C; National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead and Discipline of Child and Adolescent Health, Medical School, University of Sydney, Sydney, Australia.
Quinn H; National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead and Discipline of Child and Adolescent Health, Medical School, University of Sydney, Sydney, Australia.
Menzies R; School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.
Gilmour R; Communicable Disease Branch, Health Protection NSW, New South Wales Ministry of Health, Sydney, Australia.
McIntyre P; National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead and Discipline of Child and Adolescent Health, Medical School, University of Sydney, Sydney, Australia.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2018 Jul 18; Vol. 67 (3), pp. 367-374.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunization Schedule*
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*administration & dosage
Child ; Child, Preschool ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use ; Humans ; Immunization, Secondary ; Infant ; Infant, Newborn ; Male ; Pneumococcal Vaccines/therapeutic use ; Streptococcus pneumoniae ; Vaccine Potency
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies